Search research articles
Contact Us
Filters
Showing results (111-120 of 344) with videos related to
Page
of 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2009
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Kohei Shitara, Keitaro Matsuo, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology
|
July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer
Shuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 2, 2007
[A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil]
Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 2, 2017
Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer
Kohei Shitara, Shigenori Kadowaki, Tomohiro Nishina, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 14, 2019
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study
Kohei Shitara, Yoshitaka Honma, Yasushi Omuro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 29, 2018
Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples
Yasuhiro Oono, Takeshi Kuwata, Kenji Takashima, et al.
World Journal of Surgery
|
January 14, 2025
Area of Residual Tumor Measurement After Preoperative Chemotherapy as an Objective and Quantitative Method for Predicting the Prognosis of Gastric Cancer: A Single-Center Retrospective Study
Hiromi Nagata, Takahiro Kinoshita, Shingo Sakashita, et al.
BMC Cancer
|
November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials
Yoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 19, 2009
[A case report--gastric stenosis due to primary gastric malignant lymphoma after administration of R-CHOP]
Osamu Muto, Masaki Munakata, Kohei Shitara, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2011
Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy
Motoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
Page
of 35
Search research articles
Search
Showing results (111-120 of 344) with videos related to
Sort By:
Page
of 35
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2009
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Kohei Shitara, Keitaro Matsuo, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology
|
July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer
Shuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 2, 2007
[A case of advanced hepatocellular carcinoma with lung metastases and cirrhosis that responded to combination chemotherapy with interferon-alpha and 5-fluorouracil]
Kohei Shitara, Masaki Munakata, Toshihiro Kudo, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
July 2, 2017
Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer
Kohei Shitara, Shigenori Kadowaki, Tomohiro Nishina, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 14, 2019
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study
Kohei Shitara, Yoshitaka Honma, Yasushi Omuro, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
June 29, 2018
Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples
Yasuhiro Oono, Takeshi Kuwata, Kenji Takashima, et al.
World Journal of Surgery
|
January 14, 2025
Area of Residual Tumor Measurement After Preoperative Chemotherapy as an Objective and Quantitative Method for Predicting the Prognosis of Gastric Cancer: A Single-Center Retrospective Study
Hiromi Nagata, Takahiro Kinoshita, Shingo Sakashita, et al.
BMC Cancer
|
November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials
Yoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 19, 2009
[A case report--gastric stenosis due to primary gastric malignant lymphoma after administration of R-CHOP]
Osamu Muto, Masaki Munakata, Kohei Shitara, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2011
Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy
Motoo Nomura, Kohei Shitara, Takeshi Kodaira, et al.
Page
of 35